Tonix Pharmaceuticals Holding (TNXP) Earnings Date & Reports

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

TNXP is expected to report earnings to fall 202.82% to -292 cents per share on August 11

Tonix Pharmaceuticals Holding TNXP Stock Earnings Reports

Q2'25

Est.

$-2.92

Q1'25

Beat

by $22.84

Q4'24

Missed

by $5.86

Q3'24

Beat

by $2.70

Q2'24

Missed

by $14.05

The last earnings report on May 12 showed earnings per share of $2.84, beating the estimate of -2000 cents. With 1.58M shares outstanding, the current market capitalization sits at 291.38M.

View a ticker or compare two or three

Compare

TNXP